Takeda’s IBD Treatment ENTYVIO® (vedolizumab) Receives Prestigious Prix Galien Canada Innovative Product Award

Takeda's IBD Treatment ENTYVIO® (vedolizumab) Receives Prestigious Prix Galien Canada Innovative Product Award Oakville, ON - November 23, 2016 -/CNW/ Takeda Canada is pleased to announce that ENTYVIO® (vedolizumab), a gut-selective biologic treatment to treat the two most common types of [...]

2020-10-07T13:36:55-07:00November 29, 2016|
Go to Top